111 related articles for article (PubMed ID: 7586587)
41. Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment.
Rao F; Keiser HR; O'Connor DT
Ann N Y Acad Sci; 2002 Oct; 971():530-2. PubMed ID: 12438175
[No Abstract] [Full Text] [Related]
42. Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease.
O'Connor DT; Cervenka JH; Stone RA; Parmer RJ; Franco-Bourland RE; Madrazo I; Langlais PJ
Neuroscience; 1993 Oct; 56(4):999-1007. PubMed ID: 7904334
[TBL] [Abstract][Full Text] [Related]
43. Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis.
Kailasam MT; Parmer RJ; Stone RA; Shankel S; Kennedy BP; Ziegler MG; O'Connor DT
Am J Hypertens; 1995 Jun; 8(6):651-5. PubMed ID: 7662252
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella N; George S
Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
[TBL] [Abstract][Full Text] [Related]
45. [Pheochromocytoma. Methoxycatecholamines in nocturnal urine and chromogranin in EDTA-blood should be measured first].
Lindstedt G; Kågedal B; Ahlman H; Karlberg BE
Lakartidningen; 1998 Oct; 95(44):4859-61. PubMed ID: 9830308
[No Abstract] [Full Text] [Related]
46. Plasma 3-methoxy-4-hydroxyphenethyleneglycol in pheochromocytoma.
Lehnert H; Walger P
Cardiology; 1985; 72 Suppl 1():160-2. PubMed ID: 4053125
[TBL] [Abstract][Full Text] [Related]
47. [Chromogranin A and neuroendocrine tumors].
Díaz Pérez JÁ; Currás Freixes M
Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
[TBL] [Abstract][Full Text] [Related]
48. [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].
Leibovitch I; Pinthus Y; Sella BA; Ramon J
Harefuah; 2006 Jan; 145(1):25-9, 78. PubMed ID: 16450720
[TBL] [Abstract][Full Text] [Related]
49. Immunoluminometric assay of chromogranin A in serum with commercially available reagents.
Bender H; Maier A; Wiedenmann B; O'Connor DT; Messner K; Schmidt-Gayk H
Clin Chem; 1992 Nov; 38(11):2267-72. PubMed ID: 1424122
[TBL] [Abstract][Full Text] [Related]
50. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
51. Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations.
Pawlikowski M; Gruszka A; Radek M; Kunert-Radek J
Folia Histochem Cytobiol; 2004; 42(4):245-7. PubMed ID: 15704652
[TBL] [Abstract][Full Text] [Related]
52. Chromogranin A.
Landsberg L
N Engl J Med; 1984 Sep; 311(12):794-5. PubMed ID: 6472370
[No Abstract] [Full Text] [Related]
53. Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas.
Eder U; Fischer-Colbrie R; Kogner P; Leitner B; Bjellerup P; Winkler H
Neurosci Lett; 1998 Aug; 253(1):17-20. PubMed ID: 9754794
[TBL] [Abstract][Full Text] [Related]
54. Chromogranin A: implications for hypertension.
O'Connor DT
J Hypertens Suppl; 1984 Dec; 2(3):S147-50. PubMed ID: 6599663
[TBL] [Abstract][Full Text] [Related]
55. Malignant pheochromocytoma in a young adult forming the structure simulating Homer Wright rosette: differentiation from neuroblastoma on repeating fluorescence in situ hybridization.
Mori H; Nagata M; Nishijima N; Nagura K; Igarashi H; Hamazaki M; Ozono S; Sugimura H
Pathol Int; 2008 Aug; 58(8):518-23. PubMed ID: 18705773
[TBL] [Abstract][Full Text] [Related]
56. [Clinical significance of serum chromogranin A analysis in endocrine tests of the adrenal medulla and sympathetic nervous system].
Sato J; Yamada R
Nihon Rinsho; 1989 Dec; 48 Suppl():1161-4. PubMed ID: 2621838
[No Abstract] [Full Text] [Related]
57. The role of chromogranin A in the management of patients with phaeochromocytoma.
Grossrubatscher E; Dalino P; Vignati F; Gambacorta M; Pugliese R; Boniardi M; Rossetti O; Marocchi A; Bertuzzi M; Loli P
Clin Endocrinol (Oxf); 2006 Sep; 65(3):287-93. PubMed ID: 16918946
[TBL] [Abstract][Full Text] [Related]
58. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma.
Guignat L; Bidart JM; Nocera M; Comoy E; Schlumberger M; Baudin E
Br J Cancer; 2001 Mar; 84(6):808-12. PubMed ID: 11259096
[TBL] [Abstract][Full Text] [Related]
59. Elevated plasma chromogranin-A concentrations in prostatic carcinoma.
Kadmon D; Thompson TC; Lynch GR; Scardino PT
J Urol; 1991 Aug; 146(2):358-61. PubMed ID: 1856931
[TBL] [Abstract][Full Text] [Related]
60. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
